Cargando…
Potential molecular biomarkers used to predict the response to biological therapies in ulcerative colitis
Autores principales: | Zhang, Run-Feng, Liu, Shuang, Wang, Yun-Wei, Li, Ji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116026/ https://www.ncbi.nlm.nih.gov/pubmed/33538506 http://dx.doi.org/10.1097/CM9.0000000000001390 |
Ejemplares similares
-
What is the "optimal formula" for donor selection and feces processing for fecal microbiota transplantation in ulcerative colitis?
por: Li, Haiyue, et al.
Publicado: (2023) -
Lysosomal-associated protein transmembrane-4 beta: a novel potential biomarker for cancer therapy with multiple functions
por: Xu, Xi-Chao, et al.
Publicado: (2021) -
Biological therapy for ulcerative colitis
por: Arora, Zubin, et al.
Publicado: (2015) -
Application of serum Golgi protein-73 in the management of chronic liver disease
por: Yao, Ming-Jie, et al.
Publicado: (2021) -
Time to relapse after treatment withdrawal for different biologics used to treat plaque psoriasis
por: Wang, Xiao-Yu, et al.
Publicado: (2020)